Zelira share price rockets as study shows cannabinoid drug outperforms multibillion dollar Pfizer product by Steve Jones June 1, 2023April 30, 2024 ASX-listed Zelira Therapeutics saw its share price soar 230% yesterday after revealing its cannabinoid medication for […]